The single-dose J&J vaccine had 67% efficacy against moderate to severe-critical COVID-19 at >/=14 d. Sacks HS. Ann Intern Med 2021 Jul 6. doi: 10.7326/ACPJ202107200.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sacks HS. The single-dose J&J vaccine had 67% efficacy against moderate to severe-critical COVID-19 at >/=14 d. Ann Intern Med 2021 Jul 6. doi: 10.7326/ACPJ202107200.
PMID: 34224270